DynPort Vaccine Company LLC, a CSC company, manages product development programs for U.S. government agencies, and provides consulting services to biotechnology and pharmaceutical companies.

Lessons Learned and Best Practices in Medical Countermeasure Development
Want to learn more about working with U.S. Government agencies to develop medical countermeasures? In this new white paper, DVC presents lessons learned based on our experience over the last decade.

DVC Names Linda Dunsmoor Head of Quality
A DVC employee since 2002, Ms. Dunsmoor has 23 years of biotechnology industry experience.  As Head of Quality, she will oversee CGMP, GLP and GMP compliance.

Phacilitate Vaccine Forum 2010
Join DVC President Dr. Robert House on January 27 as he discusses successfully developing vaccines for U.S. government customers at this three day conference in Washington, D.C.